
Personalis PSNL
€ 7.62
3.62%
Quartalsbericht 2025-Q3
hinzugefügt 04.11.2025
Personalis DPO 2011-2026 | PSNL
DPO Jährlich Personalis
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 67.3 | 91.7 | 77.9 | 59.4 | 48.8 | 62.1 | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 91.7 | 48.8 | 67.9 |
DPO Vierteljährlich Personalis
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 76.4 | 65.4 | 48.7 | - | 60.2 | 60 | 78.4 | - | 55 | 75.8 | 76.8 | - | 39.8 | 40.1 | 89.6 | - | 52.1 | 52.2 | 50.3 | - | 52.3 | 51.1 | 47.2 | - | 58.1 | 67.5 | 62.9 | - | 83.5 | 46.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 89.6 | 39.8 | 60.4 |
DPO anderer Aktien in der Diagnostik & Forschung
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
21.3 | - | -17.87 % | $ 25.9 M | ||
|
Centogene N.V.
CNTG
|
120 | - | -6.23 % | $ 30.6 M | ||
|
Chembio Diagnostics
CEMI
|
52.5 | - | 0.22 % | $ 16.8 M | ||
|
Co-Diagnostics
CODX
|
106 | $ 5.83 | -2.51 % | $ 171 M | ||
|
Burning Rock Biotech Limited
BNR
|
125 | $ 23.88 | 1.85 % | $ 257 M | ||
|
Castle Biosciences
CSTL
|
52 | $ 39.0 | -1.66 % | $ 1.08 B | ||
|
Biocept
BIOC
|
56.3 | - | -13.05 % | $ 7.29 M | ||
|
Accelerate Diagnostics
AXDX
|
125 | - | -61.36 % | $ 2.46 M | ||
|
DermTech
DMTK
|
47.4 | - | -11.32 % | $ 2.94 M | ||
|
DexCom
DXCM
|
70.4 | $ 69.71 | -1.79 % | $ 26.9 B | ||
|
BioNano Genomics
BNGO
|
104 | $ 1.56 | -1.89 % | $ 1.98 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
45.8 | - | - | $ 562 M | ||
|
Guardant Health
GH
|
83.6 | $ 107.22 | -0.33 % | $ 13.2 B | ||
|
Global Cord Blood Corporation
CO
|
17.7 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
61.4 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
780 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
43.5 | - | 0.12 % | $ 80.1 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
8.98 | - | - | $ 10.7 B | ||
|
Illumina
ILMN
|
56.3 | $ 146.92 | 0.94 % | $ 23.4 B | ||
|
CareDx, Inc
CDNA
|
44.2 | $ 20.19 | -1.85 % | $ 1.09 B | ||
|
Danaher Corporation
DHR
|
66.4 | $ 234.88 | -1.74 % | $ 172 B | ||
|
IQVIA Holdings
IQV
|
126 | $ 242.76 | 0.72 % | $ 44 B | ||
|
DarioHealth Corp.
DRIO
|
43.9 | $ 12.33 | 5.61 % | $ 350 M | ||
|
Anixa Biosciences
ANIX
|
1.29 K | $ 3.16 | -0.16 % | $ 103 K | ||
|
Enzo Biochem
ENZ
|
52.3 | - | -8.98 % | $ 14.8 K | ||
|
Lantheus Holdings
LNTH
|
25.3 | $ 65.0 | -3.68 % | $ 4.5 B | ||
|
Exact Sciences Corporation
EXAS
|
139 | $ 102.26 | 0.02 % | $ 19 B | ||
|
Medpace Holdings
MEDP
|
13.3 | $ 611.73 | 2.09 % | $ 18.9 B | ||
|
Fulgent Genetics
FLGT
|
34.9 | $ 28.38 | 0.78 % | $ 858 M | ||
|
Aspira Women's Health
AWH
|
112 | - | -6.19 % | $ 10.5 M | ||
|
Motus GI Holdings
MOTS
|
1.72 | - | -34.28 % | $ 263 K | ||
|
Myriad Genetics
MYGN
|
42 | $ 6.56 | -0.23 % | $ 594 M | ||
|
National Research Corporation
NRC
|
10.1 | $ 20.42 | -0.05 % | $ 501 M | ||
|
Natera
NTRA
|
17.9 | $ 236.38 | 0.39 % | $ 23.3 B | ||
|
OPKO Health
OPK
|
43.1 | $ 1.32 | -0.75 % | $ 916 M | ||
|
Charles River Laboratories International
CRL
|
24.5 | $ 223.2 | 2.0 % | $ 11.5 B | ||
|
Heska Corporation
HSKA
|
39.7 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
112 | - | -20.0 % | $ 1.06 M | ||
|
Pacific Biosciences of California
PACB
|
33.5 | $ 2.17 | 7.96 % | $ 550 M | ||
|
Mettler-Toledo International
MTD
|
53.4 | $ 1 491.82 | -0.04 % | $ 31.7 B | ||
|
ENDRA Life Sciences
NDRA
|
1.65 K | $ 4.5 | -0.66 % | $ 2.42 M | ||
|
Invitae Corporation
NVTA
|
69 | - | - | $ 21.2 M | ||
|
Neogen Corporation
NEOG
|
62.7 | $ 9.11 | -2.83 % | $ 1.98 B | ||
|
Quest Diagnostics Incorporated
DGX
|
18.3 | $ 177.23 | 1.23 % | $ 19.7 B | ||
|
Organovo Holdings
ONVO
|
82.9 K | - | -2.3 % | $ 19.4 M |